A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors

Medical and Pediatric Oncology

Volumn 37, Issue 4, 2001, Pages 390-392

  Liu, Li ^a   Vapiwala, Neha ^b   Munoz, Louis K ^c   Winick, Naomi J ^d   Weitman, Steven ^e   Strauss, Lewis C ^f   Frankel, Lawrence S ^g   Rosenthal, David I ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d Lowe Foundation   (United States)

^e CTRC Institute for Drug Development   (United States)

^f NeoPharm Inc   (United States)

^g TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Malignant brain tumors; Paclitaxel; Radiosensitization

Indexed keywords

DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL;

ADOLESCENT; ANEMIA; ARTICLE; BRAIN RADIATION; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLIOBLASTOMA; GLIOSIS; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOSENSITIZATION;

ADOLESCENT; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; GLIOMA; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PACLITAXEL; RADIATION INJURIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034799120     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1215     Document Type: Article

References (18)

1. Brain stem gliomas: A classification system based on magnetic resonance imaging
2. Radiation therapy for brain stem tumor with special reference to CT feature and prognosis correlations
3. Chemotherapy for malignant glioma
4. Taxol (paclitaxel): Mechanisms of action
5. Cytotoxic of taxol in vitro against human and rat malignant brain tumors
6. Salvage chemotherapy with paclitaxel for recurrent primary brain tumors
7. Taxol sensitizes human astrocytoma cells to radiation
8. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel
9. Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: Phase I studies
10. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy
11. International clinical trials in radiation oncology. The late effects of toxicity scoring
12. Phase I trial of weekly paclitaxel in advanced lung cancer
13. Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: A collaborative pediatric oncology branch, national cancer institute and children's cancer group trial
14. Phase I trial of docetaxol administered as a 1-hour infusion in children with refractory solid tumors: A collaborative pediatric branch, national cancer institute and children's cancer group trial
15. Phase I trial of docetaxol with filgrastin support in pediatric patients with refractory solid tumors: A collaborative pediatric oncology branch, national cancer institute and children's cancer group trial
16. Preirradiation paclitaxel in glioblastoma multiforme: Efficacy, pharmacology, and drug interactions. New approaches to brain tumor therapy central nervous system consortium
17. Fractionated stereotactic radiosurgery and concurrent Taxol in recurrent glioblastoma multiforme: A preliminary report
18. Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas